Literature DB >> 2649955

Polymicrobial bacteremia: clinical and microbiologic patterns.

A G Reuben1, D M Musher, R J Hamill, I Broucke.   

Abstract

Between 1971 and 1987, 97 patients with polymicrobial bacteremia (PMB) were seen by a consulting infectious disease service. Seventy-four had severe underlying illnesses, and infection was hospital acquired in 80. PMB resulted from intraabdominal, urinary tract, or soft tissue infection in 45 patients, but a wide range of sources were implicated in the rest. Eleven patients had more than one source for the bacteremia, and, despite intensive diagnostic efforts, 24 had no identifiable source for at least one blood isolate. Bacteremia due to gram-negative bacilli most commonly occurred in intraabdominal, urinary tract, and wound infections; Escherichia coli and Klebsiella species were most frequently isolated. Streptococcus faecalis and Staphylococcus aureus were the predominant gram-positive isolates. Certain bacterial combinations seemed to provide a clue for predicting the source of PMB: for example, S. aureus together with gram-negative facultative rods usually arose from a skin or soft tissue source, whereas S. faecalis together with a gram-negative bacillus could often be traced to an intraabdominal infection. No unique clinical features appeared to predict the occurrence of bacteremia due to multiple rather than to a single organism. The mortality in patients was 21%, lower than has previously been described in PMB but similar to that reported for bacteremia due to a single organism.

Entities:  

Mesh:

Year:  1989        PMID: 2649955     DOI: 10.1093/clinids/11.2.161

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  22 in total

1.  Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients.

Authors:  S Sancho; A Artero; R Zaragoza; J J Camarena; R González; J M Nogueira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

2.  Case mortality in polymicrobial bloodstream infections.

Authors:  F E McKenzie
Journal:  J Clin Epidemiol       Date:  2006-05-02       Impact factor: 6.437

3.  Polymicrobial pneumococcal bacteraemia: a case-control study.

Authors:  I Grau; C Ardanuy; M H Schulze; J Liñares; R Pallares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-04       Impact factor: 3.267

4.  Early and late onset bacteremia have different risk factors in trauma patients.

Authors:  M Antonelli; M L Moro; R R D'Errico; G Conti; M Bufi; A Gasparetto
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

5.  A Flowthrough Assay for Rapid Bedside Stratification of Bloodstream Bacterial Infection in Critically Ill Patients: a Pilot Study.

Authors:  Pramod Jagtap; Rohini Singh; Karuna Deepika; Venkataraman Sritharan; Shalini Gupta
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

Review 6.  A 'culture' shift: Application of molecular techniques for diagnosing polymicrobial infections.

Authors:  Yi Zhang; Anne Hu; Nadya Andini; Samuel Yang
Journal:  Biotechnol Adv       Date:  2019-02-20       Impact factor: 14.227

7.  Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes.

Authors:  J Rello; M Ricart; B Mirelis; E Quintana; M Gurgui; A Net; G Prats
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  Anaerobic bacteremia in a cancer center.

Authors:  L M Noriega; P Van der Auwera; M Phan; D Daneau; F Meunier; J Gerain; M Aoun
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

9.  Polymicrobial bacteremia in critically ill patients.

Authors:  J Rello; E Quintana; B Mirelis; M Gurguí; A Net; G Prats
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 10.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.